A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

April 17, 2025

Study Completion Date

April 17, 2026

Conditions
Pancreatic Cancer
Interventions
DRUG

Disitamab Vedotin

Disitamab Vedotin

DRUG

Gemcitabine

Gemcitabine

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT06233864 - A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter